Another study that included 35 pure-type (73.9% with endometriosis) and 11 mixed-type clear cell carcinomas (45.5% with endometriosis) showed that both ARID1A and p53 were mutually altered in pure-type clear cell carcinoma, at immunohistochemical analysis. Here, TP53 is linked to clear cell adenocarcinoma.